• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For September 5, 2023

    9/5/23 6:37:16 AM ET
    $ASAN
    $ASND
    $AVAV
    $BRC
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ASAN alert in real time by email

    Companies Reporting Before The Bell

    • Procaps Gr (NASDAQ:PROC) is likely to report earnings for its second quarter.

    • America's Car-Mart (NASDAQ:CRMT) is estimated to report quarterly earnings at $0.91 per share on revenue of $352.12 million.

    • Tower Semiconductor (NASDAQ:TSEM) is expected to report quarterly earnings at $0.51 per share on revenue of $359.11 million.

    • Brady (NYSE:BRC) is estimated to report quarterly earnings at $0.93 per share on revenue of $329.19 million.

    Companies Reporting After The Bell

    • Ascendis Pharma (NASDAQ:ASND) is projected to report quarterly loss at $2.77 per share on revenue of $41.73 million.

    • AeroVironment (NASDAQ:AVAV) is expected to report quarterly earnings at $0.26 per share on revenue of $128.50 million.

    • Asana (NYSE:ASAN) is estimated to report quarterly loss at $0.11 per share on revenue of $157.91 million.

    • GitLab (NASDAQ:GTLB) is projected to report quarterly loss at $0.03 per share on revenue of $129.79 million.

    • Zscaler (NASDAQ:ZS) is projected to report quarterly earnings at $0.49 per share on revenue of $430.38 million.

    • HealthEquity (NASDAQ:HQY) is expected to report quarterly earnings at $0.48 per share on revenue of $240.09 million.

    • Grindrod Shipping Hldgs (NASDAQ:GRIN) is expected to report quarterly loss at $0.21 per share on revenue of $37.10 million.

    • Brasilagro - Cia Bras (NYSE:LND) is likely to report earnings for its fourth quarter.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ASAN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASAN
    $ASND
    $AVAV
    $BRC

    CompanyDatePrice TargetRatingAnalyst
    Ascendis Pharma A/S
    $ASND
    1/28/2026$342.00Overweight
    Barclays
    Asana Inc.
    $ASAN
    1/15/2026$16.00Neutral → Buy
    Citigroup
    GitLab Inc.
    $GTLB
    1/12/2026$34.00Equal Weight → Underweight
    Barclays
    GitLab Inc.
    $GTLB
    1/12/2026$42.00Overweight → Equal-Weight
    Morgan Stanley
    HealthEquity Inc.
    $HQY
    1/9/2026$89.00Neutral → Sell
    Goldman
    GitLab Inc.
    $GTLB
    1/7/2026$40.00Overweight → Neutral
    Cantor Fitzgerald
    Tower Semiconductor Ltd.
    $TSEM
    12/31/2025$125.00Outperform → Neutral
    Wedbush
    AeroVironment Inc.
    $AVAV
    12/19/2025$285.00Overweight
    KeyBanc Capital Markets
    More analyst ratings

    $ASAN
    $ASND
    $AVAV
    $BRC
    SEC Filings

    View All

    SEC Form 6-K filed by Ascendis Pharma A/S

    6-K - Ascendis Pharma A/S (0001612042) (Filer)

    2/11/26 4:50:29 PM ET
    $ASND
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 20-F filed by Ascendis Pharma A/S

    20-F - Ascendis Pharma A/S (0001612042) (Filer)

    2/11/26 4:15:33 PM ET
    $ASND
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Ascendis Pharma A/S

    SCHEDULE 13G/A - Ascendis Pharma A/S (0001612042) (Subject)

    2/11/26 10:57:26 AM ET
    $ASND
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASAN
    $ASND
    $AVAV
    $BRC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ascendis Pharma Reports Fourth Quarter and Full-Year 2025 Financial Results

    Q4 2025 product revenue of €240 million and FY 2025 product revenue of €684 millionQ4 2025 operating profit of €10 million and cash flow from operating activities of €73 millionTransCon® CNP under FDA Priority Review, PDUFA action goal date of February 28, 2026Conference call today at 4:30 pm ET COPENHAGEN, Denmark, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (NASDAQ:ASND) today announced financial results for the fourth quarter and full year ended December 31, 2025, and provided a business update. "With a continued focus on making a meaningful difference for patients, we believe Ascendis is entering a steep growth phase as we transform into a leading global biopharma company,"

    2/11/26 4:01:00 PM ET
    $ASND
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AV Welcomes Stephen Voline as Senior Director, Washington Operations

    Experienced defense policy and government relations leader brings decades of military, legislative, and industry expertise to AV's Washington Operations team AeroVironment, Inc. ("AV") (NASDAQ:AVAV), a global defense technology leader, today announced that Stephen Voline has joined the company as Senior Director of Washington Operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260211855975/en/Stephen Voline brings more than three decades of experience across military operations, defense policy, and industry advocacy. Voline will support AV's engagement with Congress, the Department of War, and key national security stak

    2/11/26 7:30:00 AM ET
    $AVAV
    Aerospace
    Industrials

    Tower Semiconductor Reports Record Revenue for the Fourth Quarter of 2025

    MIGDAL HAEMEK, Israel, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Tower Semiconductor (NASDAQ/TASE: TSEM) reports today its results for the fourth quarter of 2025 and for the year ended December 31, 2025. Fourth Quarter of 2025 Results OverviewRecord revenue for the fourth quarter of 2025 was $440 million, representing revenue growth of 14% year-over-year and 11% quarter-over-quarter. The Company met its expressed revenue target of sequential quarter-over-quarter revenue growth within 2025 and an acceleration in the second half of the year, resulting in 23% growth fourth quarter over first quarter. Gross profit and operating profit for the fourth quarter of 2025 were $118 million

    2/11/26 7:00:00 AM ET
    $TSEM
    Semiconductors
    Technology

    $ASAN
    $ASND
    $AVAV
    $BRC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on Ascendis Pharma with a new price target

    Barclays initiated coverage of Ascendis Pharma with a rating of Overweight and set a new price target of $342.00

    1/28/26 7:15:39 AM ET
    $ASND
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Asana upgraded by Citigroup with a new price target

    Citigroup upgraded Asana from Neutral to Buy and set a new price target of $16.00

    1/15/26 8:27:19 AM ET
    $ASAN
    Computer Software: Prepackaged Software
    Technology

    GitLab downgraded by Barclays with a new price target

    Barclays downgraded GitLab from Equal Weight to Underweight and set a new price target of $34.00

    1/12/26 8:05:47 AM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    $ASAN
    $ASND
    $AVAV
    $BRC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Staples William bought $124,750 worth of shares (3,276 units at $38.08), increasing direct ownership by 0.96% to 345,671 units (SEC Form 4)

    4 - Gitlab Inc. (0001653482) (Issuer)

    1/5/26 6:26:25 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    Chief Financial Officer Collins Jonathan M. bought $4,978 worth of shares (197 units at $25.27), increasing direct ownership by 3% to 6,444 units (SEC Form 4)

    4 - AMERICAS CARMART INC (0000799850) (Issuer)

    12/12/25 9:25:57 PM ET
    $CRMT
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Director Moskovitz Dustin A. bought $1,655,954 worth of shares (122,470 units at $13.52), increasing direct ownership by 0.21% to 57,898,436 units (SEC Form 4)

    4 - Asana, Inc. (0001477720) (Issuer)

    8/25/25 6:47:51 PM ET
    $ASAN
    Computer Software: Prepackaged Software
    Technology

    $ASAN
    $ASND
    $AVAV
    $BRC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CFO Mcdonnell Kevin Patrick sold $235,220 worth of shares (879 units at $267.60) (SEC Form 4)

    4 - AeroVironment Inc (0001368622) (Issuer)

    2/11/26 4:48:49 PM ET
    $AVAV
    Aerospace
    Industrials

    Director Cohler Matt was granted 823 shares, increasing direct ownership by 0.24% to 339,849 units (SEC Form 4)

    4 - Asana, Inc. (0001477720) (Issuer)

    2/4/26 6:02:27 PM ET
    $ASAN
    Computer Software: Prepackaged Software
    Technology

    Director Anderson-Copperman Krista was granted 1,268 shares, increasing direct ownership by 2% to 65,788 units (SEC Form 4)

    4 - Asana, Inc. (0001477720) (Issuer)

    2/4/26 5:49:45 PM ET
    $ASAN
    Computer Software: Prepackaged Software
    Technology

    $ASAN
    $ASND
    $AVAV
    $BRC
    Financials

    Live finance-specific insights

    View All

    Ascendis Pharma Reports Fourth Quarter and Full-Year 2025 Financial Results

    Q4 2025 product revenue of €240 million and FY 2025 product revenue of €684 millionQ4 2025 operating profit of €10 million and cash flow from operating activities of €73 millionTransCon® CNP under FDA Priority Review, PDUFA action goal date of February 28, 2026Conference call today at 4:30 pm ET COPENHAGEN, Denmark, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (NASDAQ:ASND) today announced financial results for the fourth quarter and full year ended December 31, 2025, and provided a business update. "With a continued focus on making a meaningful difference for patients, we believe Ascendis is entering a steep growth phase as we transform into a leading global biopharma company,"

    2/11/26 4:01:00 PM ET
    $ASND
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Tower Semiconductor Reports Record Revenue for the Fourth Quarter of 2025

    MIGDAL HAEMEK, Israel, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Tower Semiconductor (NASDAQ/TASE: TSEM) reports today its results for the fourth quarter of 2025 and for the year ended December 31, 2025. Fourth Quarter of 2025 Results OverviewRecord revenue for the fourth quarter of 2025 was $440 million, representing revenue growth of 14% year-over-year and 11% quarter-over-quarter. The Company met its expressed revenue target of sequential quarter-over-quarter revenue growth within 2025 and an acceleration in the second half of the year, resulting in 23% growth fourth quarter over first quarter. Gross profit and operating profit for the fourth quarter of 2025 were $118 million

    2/11/26 7:00:00 AM ET
    $TSEM
    Semiconductors
    Technology

    Brady Corporation Announces Earnings Conference Call

    MILWAUKEE, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Brady Corporation (NYSE:BRC), will announce its fiscal 2026 second quarter financial results on Thursday, February 19, 2026.   A conference call will be held beginning at 10:30 a.m. Eastern Time (9:30 a.m. Central Time) Thursday, February 19, 2026. Participants will be able to access the webcast and presentation here live and in replay. This call is being webcast by Notified and can be accessed here. About BRCBrady Corporation is an international manufacturer and marketer of complete solutions that identify and protect people, products and places. Brady's products help customers increase safety, security, productivity and performance and incl

    2/10/26 2:05:00 PM ET
    $BRC
    Miscellaneous manufacturing industries
    Consumer Discretionary

    $ASAN
    $ASND
    $AVAV
    $BRC
    Leadership Updates

    Live Leadership Updates

    View All

    AV Welcomes Stephen Voline as Senior Director, Washington Operations

    Experienced defense policy and government relations leader brings decades of military, legislative, and industry expertise to AV's Washington Operations team AeroVironment, Inc. ("AV") (NASDAQ:AVAV), a global defense technology leader, today announced that Stephen Voline has joined the company as Senior Director of Washington Operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260211855975/en/Stephen Voline brings more than three decades of experience across military operations, defense policy, and industry advocacy. Voline will support AV's engagement with Congress, the Department of War, and key national security stak

    2/11/26 7:30:00 AM ET
    $AVAV
    Aerospace
    Industrials

    Zscaler Appoints Dr. Swamy Kocherlakota as Executive Vice President of Agentic AI Security Engineering

    SAN JOSE, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ:ZS), the leader in cloud security, today announced the appointment of Dr. Swamy Kocherlakota as Executive Vice President of Agentic AI Security Engineering to address a fundamental shift: AI is evolving from chat bots into autonomous agents that function as both users and applications. This shift breaks legacy security models and introduces a new spectrum of advanced threats. Dr. Kocherlakota will lead Zscaler's strategy to solve the problem at the architectural level, where traditional vendors attempt to patch these risks with isolated tools. "Agentic AI is the future of how organizations will work, creating enormo

    1/12/26 4:05:00 PM ET
    $ZS
    EDP Services
    Technology

    GitLab Appoints Siva Padisetty as Chief Technology Officer

    Veteran engineering leader brings two decades of experience scaling cloud platforms and modernizing enterprise systems All-Remote - GitLab Inc., the most comprehensive intelligent DevSecOps platform, today announced the appointment of Siva Padisetty as Chief Technology Officer, effective January 15, 2026. Padisetty will lead GitLab's software engineering, operations, and customer support teams to execute the company's technical vision and strategy and oversee the development and delivery of GitLab's products. He succeeds Sabrina Farmer, who stepped down from her role and will remain in an advisory capacity to ensure a seamless transition through January 31, 2026. This press release featu

    1/12/26 9:05:00 AM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    $ASAN
    $ASND
    $AVAV
    $BRC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Tower Semiconductor Ltd.

    SC 13G - TOWER SEMICONDUCTOR LTD (0000928876) (Subject)

    12/9/24 9:15:24 AM ET
    $TSEM
    Semiconductors
    Technology

    Amendment: SEC Form SC 13D/A filed by Procaps Group S.A.

    SC 13D/A - Procaps Group, S.A. (0001863362) (Subject)

    12/3/24 7:20:10 PM ET
    $PROC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Ascendis Pharma A/S

    SC 13G/A - Ascendis Pharma A/S (0001612042) (Subject)

    11/14/24 5:46:12 PM ET
    $ASND
    Biotechnology: Pharmaceutical Preparations
    Health Care